Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
18 studies found for:    "Genital Diseases, Female" | Mexico
Show Display Options
Rank Status Study
1 Active, not recruiting TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Drug: AMG 386;   Drug: AMG 386 Placebo;   Drug: Paclitaxel
2 Active, not recruiting A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: carboplatin;   Drug: Paclitaxel
3 Completed
Has Results
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
Condition: Menorrhagia
Interventions: Drug: Levonorgestrel IUS (Mirena, BAY86-5028);   Drug: Medroxyprogesterone acetate
4 Completed Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
Condition: Ovarian Cancer
Interventions: Drug: MORAb-003 (farletuzumab);   Drug: 0.9% Saline
5 Completed
Has Results
A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis
Conditions: Vaginitis;   Infectious Vaginosis
Interventions: Drug: Gynoclin V;   Drug: Vagitrol V
6 Recruiting Laparoscopic Approach to Cervical Cancer
Condition: Cervical Cancer
Interventions: Procedure: Total Abdominal Radical Hysterectomy;   Procedure: Total Laparoscopic or Robotic Radical Hysterectomy
7 Enrolling by invitation Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma
Conditions: Cervical Cancer Recurrent or Persistent;   Palliative Treatment;   Monoclonal Antibody in Cervical Cancer Treatment
Interventions: Drug: mAb Nimotuzumab;   Device: Placebo
8 Completed Reducing HIV Risk Among Mexican Youth
Conditions: HIV Infections;   AIDS;   Sexually Transmitted Diseases
Interventions: Behavioral: Adolescent Safer Sex Intervention;   Behavioral: Parent Safer Sex Communication Intervention;   Other: Adolescent Health Promotion Control Condition;   Other: Parent Health Promotion Control Condition
9 Completed Share Safer Sex Counseling Program for Changing Sexual Risk Behaviors in Mexican Female Sex Workers
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: Share Safer Sex program;   Behavioral: Standard didactic safer-sex counseling program
10 Unknown  Hydralazine Valproate for Cervical Cancer
Condition: Metastatic Cervical Cancer
Interventions: Drug: Hydralazine and magnesium valproate;   Drug: Placebo
11 Completed
Has Results
Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
Conditions: Neoplasms, Uterine Cervix;   Metastatic Cervical Cancer
Interventions: Drug: pazopanib (GW786034);   Drug: lapatinib (GW572016)
12 Completed
Has Results
Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix
Condition: Cancer of Cervix
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Radiation: Brachytherapy;   Radiation: Pelvic radiation
13 Unknown  Hydralazine Valproate for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Hydralazine and magnesium valproate;   Drug: Placebo
14 Unknown  Safer Sex Intervention for Male Clients of Female Sex Workers in Tijuana, Mexico
Conditions: HIV;   Sexually Transmitted Diseases
Interventions: Behavioral: Hombre Seguro;   Behavioral: Didactic attention-control condition
15 Unknown  Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Conditions: Pregestational Obesity (BMI > 27kg/m2);   History of Polycystic Ovary Syndrome
Interventions: Drug: medical nutrition therapy + metformin;   Behavioral: Medical nutrition therapy
16 Completed Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Hydralazine and magnesium valproate;   Procedure: Punch biopsy of the primary tumor
17 Recruiting Cervical Cancer Screening With Human Papillomavirus Testing
Conditions: CIN3;   CIN2;   Cervical Cancer
Intervention: Other: HPV screening
18 Active, not recruiting A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
Condition: Uterine Cervical Cancer
Interventions: Drug: Nimotuzumab;   Drug: Cisplatin;   Drug: Gemcitabine;   Procedure: CT Scan

Indicates status has not been verified in more than two years